Ubs Group Ag Tff Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.31 - $0.48 $11,429 - $17,697	-36,870 Reduced 28.67%	91,720 $32,000
Q2 2023 Aug 11, 2023	SELL	$0.43 - $0.77 $511 - $916	-1,190 Reduced 0.92%	128,590 $60,000
Q1 2023 May 12, 2023	BUY	$0.62 - $1.1 $9,739 - $17,279	15,709 Added 13.77%	129,780 $88,000
Q4 2022 Feb 08, 2023	BUY	$0.84 - $100.75 $13,828 - $1.66 Million	16,462 Added 16.87%	114,071 $119,000
Q3 2022 Nov 10, 2022	BUY	$4.61 - $116.0 $25,041 - $630,112	5,432 Added 5.89%	97,609 $396,000
Q2 2022 Aug 10, 2022	BUY	$3.99 - $7.22 $40,390 - $73,088	10,123 Added 12.34%	92,177 $521,000
Q1 2022 May 16, 2022	SELL	$5.28 - $9.17 $25,792 - $44,795	-4,885 Reduced 5.62%	82,054 $518,000
Q4 2021 Feb 14, 2022	BUY	$6.86 - $9.65 $48,987 - $68,910	7,141 Added 8.95%	86,939 $771,000
Q3 2021 Nov 15, 2021	BUY	$7.21 - $10.49 $538,370 - $783,288	74,670 Added 1456.12%	79,798 $616,000
Q2 2021 Aug 13, 2021	SELL	$8.48 - $13.61 $6,843 - $10,983	-807 Reduced 13.6%	5,128 $49,000
Q1 2021 May 12, 2021	SELL	$12.96 - $19.75 $119,672 - $182,371	-9,234 Reduced 60.87%	5,935 $81,000
Q4 2020 Feb 11, 2021	BUY	$12.74 - $18.49 $178,270 - $258,730	13,993 Added 1189.88%	15,169 $217,000
Q3 2020 Nov 12, 2020	SELL	$5.86 - $18.47 $12,933 - $40,763	-2,207 Reduced 65.24%	1,176 $22,000
Q2 2020 Jul 31, 2020	BUY	$3.79 - $6.08 $5,639 - $9,047	1,488 Added 78.52%	3,383 $19,000
Q1 2020 May 01, 2020	BUY	$3.51 - $5.36 $4,882 - $7,455	1,391 Added 275.99%	1,895 $7,000
Q4 2019 Feb 14, 2020	BUY	$4.71 - $5.4 $2,373 - $2,721	504 New	504 $3,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.92M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.